Skip to main content
. 2021 Nov 2;11:21522. doi: 10.1038/s41598-021-00726-4

Figure 2.

Figure 2

Forest plot showing the risk difference for studies in ICU setting in mortality between patients treated with IL-6 (receptor) antagonists and patients not treated with IL-6 (receptor) antagonists. I2 was 0%. The Metafor R package was used to generate this figure13,23. IL6Ra = IL-6 (receptor) antagonist, TCZ = tocilizumab, SAR = sarilumab, * = RCT.